HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Small-, medium-sized businesses would benefit from harmonization efforts.

This article was originally published in The Rose Sheet

Executive Summary

LABEL HARMONIZATION WOULD ADDRESS SMALL, MEDIUM BUSINESS TRADE CONCERNS by eliminating the need for producing multiple labels to comply with varying regulations, which often proves costly, according to French National Perfumery, Beauty and Toiletry Association (FIP) International Regulations Committee Chairman Gilles Guesperau. Global harmonization would solve problems including the need for labels in national languages, countries' varying definitions of SPF and different meanings for formulation batch numbers, he said. Guesperau made his remarks at the Global Cosmetic Regulatory Harmonization conference sponsored by the Italian cosmetics association UNIPRO and the European Cosmetic, Toiletry and Perfumery Association (COLIPA) in Florence, Italy, April 22-23.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005382

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel